title: Antidementia agents: what is important in this class.
authors.affiliation: Health Policy Institute, University of the Sciences, Philadelphia, USA.
authors.forename: Richard G
authors.initials: RG
authors.lastname: Stefanacci
authors.forename: Angela C
authors.initials: AC
authors.lastname: Cafiero
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000201:enzymology; D002800:Cholinesterase Inhibitors / Q000191:economics / Q000627:therapeutic use*; D017850:Economics, Pharmaceutical; D005260:Female; D005569:Formularies as Topic; D006801:Humans; D007356:Insurance, Pharmaceutical Services; D008297:Male; D006278:Medicare; D008559:Memantine / Q000627:therapeutic use; D010606:Pharmacy and Therapeutics Committee; D014481:United States
chemical_list: D002800:Cholinesterase Inhibitors; D008559:Memantine